Caldesmon isoform associated with phenotypic modulation of mesangial cells

Experimental Nephrology

Volumn 8, Issue 1, 2000, Pages 20-27

  Okamoto, Kazunori ^a   Kashihara, Naoki ^a   Yamasaki, Yasushi ^a   Kanao, Koichiro ^a   Maeshima, Yohei ^a   Sekikawa, Takashi ^a   Sugiyama, Hitoshi ^a   Murakami, Takuro ^a   Makino, Hirofumi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Caldesmon; Contractile protein; Cytoskeletal protein; Glomerular injury; Mesangial cell

Indexed keywords

CALDESMON; CONTRACTILE PROTEIN; CYTOSKELETON PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLOMERULOPATHY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MESANGIUM CELL; MOLECULAR WEIGHT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

EID: 0033972345     PISSN: 10187782     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020644     Document Type: Article

References (41)

1. Schlondorff D: The glomerular mesangial cell: An expanding role for a specialized pericyte. FASEB J 1987;1:272-281.
2. Kreisberg JL: Cell biology and biochemistry of the glomerular mesangium. Miner Electrol Metab 1988;14:167-175.
3. Makino H, Hironaka K, Shikata K, Nagake Y, Kumagai I, Kashihara N, Ota Z: Mesangial matrices act as mesangial channels to juxtaglomerular zone: Tracer and high-resolution scanning electron microscopic study. Nephron 1994;66:181-188.
4. Abrass CK, Peterson CV, Raugi G: Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats. Diabetes 1988;37:1695-1702.
5. Okamoto K, Kashihara N, Sugiyama H, Sekikawa T, Maeshima Y, Kanao K, Satoh M, Maruyama K, Odawara M, Kasahara J, Sugaya T, Murakami K, Makino H: Suppression of phenotypic alteration of mesangial cells in diabetes induced in angiotensin II type 1a receptor deficient mice. J Am Soc Nephrol 1997;8: 644A.
6. Okamoto K, Kashihara N, Sugiyama H, Sekikawa T, Maeshima Y, Kanao K, Makino H, Ota Z: Characterization of caldesmon isoform in mesangial cell and analysis of expression mechanisms. J Am Soc Nephrol 1995;6:1026.
7. Makino H, Kashihara N, Sugiyama H, Kanao K, Sekikawa T, Okamoto K, Maeshima Y, Ota Z, Nagai R: Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes. Diabetes 1996;45:488-495.
8. Makino H, Kashihara N, Sugiyama H, Kanao K, Sekikawa T, Shikata K, Nagai R, Ota Z: Phenotypic changes of the mesangium in diabetic nephropathy. J Diabetes Complications 1995;9:282-284.
9. Johnson RJ: The glomerular response to injury: Progression or resolution? Kidney Int 1994;45: 1769-1782.
10. Alpers CE, Hudkins KL, Gown AM, Johnson RJ: Enhanced expression of 'muscle-specific' actin in glomerulonephritis. Kidney Int 1992; 41:1134-1142.
11. Johnson RJ, Floege J, Yoshimura A, Iida H, Couser WG, Alpers CE: The activated mesangial cells: A glomerular 'myofibroblast'? J Am Soc Nephrol 1992;2:S190-S197.
12. Drenckhahn D, Schnittler H, Noniling R, Kriz W: Ultrastructural organization of contractile proteins in rat glomerular mesangial cells. Am J Pathol 1990;137:1343-1351.
13. Ishino T, Kobayashi R, Wakui H, Fukushima Y, Nakamoto Y, Miura AB: Biochemical characterization of contractile proteins of rat cultured mesangial cells. Kidney Int 1991;39: 1118-1124.
14. Elger M, Drenckhahn D, Nobiling R, Mundel P, Kruz W: Cultured rat mesangial cells contain smooth muscle α-actin not found in vivo. Am J Pathol 1993;1423:497-503.
15. Makino H, Shikata K, Wieslander J, Wada J, Kashihara N, Yoshioka K, Ota Z: Localization of fibril/microfibril and basement membrane collagens in diabetic glomerulosclerosis in type 2 diabetes. Diabet Med 1994;11:304-311.
16. Ueki N, Sobue K, Kanda K, Hada T, Higashino K: Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells. Proc Natl Acad Sci USA 1987;84:9049-9053.
17. Glukhova MA, Kabakov AE, Frid MG, Ornatsky OI, Belkin AM, Mukhin DN, Orekhov AN, Koteliansky VE, Simirnov UN: Modulation of human aorta smooth muscle cell phenotype: A study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci USA 1988;85:9542-9546.
18. Novy RE, Lin JLC, Lin JJC: Characterization of cDNA clones encoding a human fibroblast caldesmon isoform and analysis of caldesmon expression in normal and transformed cells. J Biol Chem 1991;266:16917-16924.
19. Yamashiro S, Yamakita Y, Yoshida K, Takiguchi K, Matsumura F: Characterization of COOH terminus of non-muscle caldesmon mutants lacking mitosis-specific phosphorylation sites. J Biol Chem 1995;270:4023-4030.
20. Humphrey MB, Herrera-Sosa H, Gonzalez G, Lee R, Bryan J: Cloning of cDNAs encoding human caldesmons. Gene 1992;112:197-204.
21. Hayashi K, Yano H, Hashida T, Takeuchi R, Takeda O, Asada K, Takahashi E, Kato I, Sobue K: Genomic structure of human caldesmon gene. Proc Natl Acad Sci USA 1992;89: 12122-12126.
22. Payne AM, Yue P, Pritchard K, Marston SB: Caldesmon mRNA splicing and isoform expression in mammalian smooth-muscle and non-muscle tissues. Biochem J 1995;305:445-450.
23. Harper PA, Robinson JM, Hoover RL, Wright TC, Karnovsky MJ: Improved methods for culturing rat glomerular cells. Kidney Int 1984;26: 875-880.
24. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z: Reactive oxygen species induce apoptosis in cultured human mesangial cells. J Am Soc Nephrol 1996;7:2357-2363.
25. Kreisberg J, Karnovsky MJ: Glomerular cells in culture. Kidney Int 1983;23:439-447.
26. Kocher O, Skalli O, Cerutti D, Gabbiani G: Cytoskeletal features of rat aortic cells during development. An electron microscopic, immunohistochemical, and biochemical study. Circ Res 1985;56:829-838.
27. Maeshima Y, Kashihara N, Yasuda T, Sugiyama H, Sekikawa T, Okamoto K, Kanao K, Watanabe Y, Kanwer YS, Makino H: Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo. J Clin Invest 1998;101:2589-2597.
28. Sugiyama H, Kashihara N, Makino H, Yamasaki Y, Ota Z: Apoptosis in glomerular sclerosis. Kidney Int 1996;49:103-111.
29. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
30. Onbe T, Kashihara N, Yamasaki Y, Makino H, Ota Z: Expression of mRNAs of cytokines and growth factors in experimental glomerulonephritis. Res Commun Mol Pathol Pharmacol 1994;86:131-138.
31. Sekikawa T, Kashihara N, Maruyama K, Satoh M, Okamoto K, Kanao K, Maeshima Y, Sugiyama H, Yamasaki Y, Makino H: Expression of interleukin-8 in human glomerulonephritis. Res Commun Mol Pathol Pharmacol 1998;99: 217-224.
32. Maeshima Y, Kashihara N, Sugiyama H, Makino H, Ota Z: Antisense oligonucleotides to proliferating cell nuclear antigen and Ki-67 inhibit human mesangial cell proliferation. J Am Soc Nephrol 1996;7:2219-2229.
33. Ando Y, Moriyama T, Miyazaki M, Akagi Y, Kawada N, Isaka Y, Izumi M, Yokoyama K, Yamauchi A, Horio M, Ando A, Ueda N, Sobue K, Imai E, Hori M: Enhanced glomerular expression of caldesmon in IgA nephropathy and its suppression by glucocorticoid-heparin therapy. Nephrol Dial Transplant 1998;13: 1168-1175.
34. Min B, Foster DN: The 5′-flanking region of the mouse vascular smooth muscle α-actin gene contains evolutionarily conserved sequence motifs within a functional promoter. J Biol Chem 1990;265:16667-16675.
35. Shimizu RT, Blank RS, Jervis R, Lawrenz-Smith SC, Owens GK: The smooth muscle α-actin gene promoter is differentially regulated in smooth muscle versus non-smooth muscle cells. J Biol Chem 1995;270:7631-7643.
36. Hautmann BB, Thompson MM, Swartz EA, Olson EN, Owens GK: Angiotensin II induced stimulation of smooth muscle alpha-actin expression by serum response factor and the homeodomain transcription factor Mhox. Circ Res 1997;81:600-610.
37. Kitamura M, Kawachi H: Creation of an in vivo cytosensor using engineered mesangial cells. Automatic sensing of glomerular inflammation controls transgene activity. J Clin Invest 1997;100:1394-1399.
38. Yano H, Hayashi K, Haruna M, Sobue K: Identification of two distinct promoters in the chicken caldesmon gene. Biochem Biophys Res Commun 1994;201:618-626.
39. Yano H, Hayashi K, Momiyama T, Saga H, Haruna M, Sobue K: Transcriptional regulation of the chicken caldesmon gene. Activation of gizzard-type caldesmon promoter requires a CArG box-like motif. J Biol Chem 1995;270: 23661-23666.
40. Momiyama T, Hayashi K, Obata H, Nishida T, Ito T, Kamiike W, Matsuda H, Sobue K: Functional involvement of serum response factor in the transcriptional regulation of caldesmon gene. Biochem Biophys Res Commun 1998; 242:429-435.
41. Toutant M, Gauthier-Rouviere C, Fiszman MY, Lemonnier M: Promoter elements and transcriptional control of the chicken tropomyosin gene. Nucleic Acids Res 1994;22: 1838-1845.